FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Johannes Schwarz

Research Profile

Disorders

Parkinson's Disease

Procedures

Single-Photon Emission-Computed Tomography

Anatomy

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Karl Strecker; Florian Wegner; Michael Adamaszek; Jürgen Beck; Sven Ohm; Johannes Schwarz
The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice.
Matthias Löhle; Claire Poulet; Ursula Ravens; Hans R Schöler; Johannes Schwarz; Sigrid C Schwarz; Hannes Glass; Andreas Hermann; Andrea Kempe; Jeong Beom Kim; Alexander Storch
Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
Kai F Loewenbrück; Jürgen Schiller; Johannes Schwarz; Sigrid Schwarz; Moritz Brandt; Beate Fuchs; Andreas Hermann; Matthias Kirsch; Annett Werner; Alexander Storch
Proton MR spectroscopy of neural stem cells: does the proton-NMR peak at 1.28 ppm function as a biomarker for cell type or state?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Johannes Schwarz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Karl Strecker; Florian Wegner; Michael Adamaszek; Jürgen Beck; Sven Ohm; Johannes Schwarz
The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice.
Journal of neural transmission (Vienna, Austria : 1996) 2012;119(11):1351-9.
2012: Matthias Löhle; Claire Poulet; Ursula Ravens; Hans R Schöler; Johannes Schwarz; Sigrid C Schwarz; Hannes Glass; Andreas Hermann; Andrea Kempe; Jeong Beom Kim; Alexander Storch
Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
Stem cells (Dayton, Ohio) 2012;30(3):570-9.
2011: Kai F Loewenbrück; Jürgen Schiller; Johannes Schwarz; Sigrid Schwarz; Moritz Brandt; Beate Fuchs; Andreas Hermann; Matthias Kirsch; Annett Werner; Alexander Storch
Proton MR spectroscopy of neural stem cells: does the proton-NMR peak at 1.28 ppm function as a biomarker for cell type or state?
Rejuvenation research 2011;14(4):371-81.
2011: Marco Skardelly; Johannes Schwarz; Khaled Gaber; Javorina Milosevic
Neuroprotective effects of the beta-catenin stabilization in an oxygen- and glucose-deprived human neural progenitor cell culture system.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2011;29(5):543-7.
2011: Johannes Schwarz; P Odin; C Buhmann; I Csoti; W Jost; Ullrich Wüllner; Alexander Storch
Depression in Parkinson's disease.
Journal of neurology 2011;258(Suppl 2):S336-8.
2011: Marco Skardelly; Khaled Gaber; Swen Burdack; Franziska Scheidt; Heidegard Hilbig; Johannes Boltze; Annette Förschler; Sigrid Schwarz; Johannes Schwarz; Jürgen Meixensberger; Martin U Schuhmann
Long-term benefit of human fetal neuronal progenitor cell transplantation in a clinically adapted model after traumatic brain injury.
Journal of neurotrauma 2011;28(3):401-14.
2011: Karl Strecker; Florian Wegner; Swen Hesse; Georg-Alexander Becker; Marianne Patt; Philipp M Meyer; Donald Lobsien; Johannes Schwarz; Osama Sabri
Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter.
Journal of neurology 2011;258(1):19-26.
2010: Martin Wolz; Matthias Löhle; Karl Strecker; Uta Schwanebeck; Christine Schneider; Heinz Reichmann; Xina Grählert; Johannes Schwarz; Alexander Storch
Levetiracetam for levodopa-induced dyskinesia in Parkinson's disease: a randomized, double-blind, placebo-controlled trial.
Journal of neural transmission (Vienna, Austria : 1996) 2010;117(11):1279-86.
2010: Martina Maisel; Hans-Jörg Habisch; Loïc Royer; Alexander Herr; Javorina Milosevic; Andreas Hermann; Stefan Liebau; Rolf Brenner; Johannes Schwarz; Michael Schroeder; Alexander Storch
Genome-wide expression profiling and functional network analysis upon neuroectodermal conversion of human mesenchymal stem cells suggest HIF-1 and miR-124a as important regulators.
Experimental cell research 2010;316(17):2760-78.
2010: Johannes Schwarz
[Nuclear medicine imaging in patients with Parkinson's syndrome: an update].
Der Nervenarzt 2010;81(10):1160-7.
2010: Sigrid C Schwarz; Johannes Schwarz
Translation of stem cell therapy for neurological diseases.
Translational research : the journal of laboratory and clinical medicine 2010;156(3):155-60.
2010: Johannes Schwarz; Alexander Storch
Transplantation in Parkinson's disease: will mesenchymal stem cells help to reenter the clinical arena?
Translational research : the journal of laboratory and clinical medicine 2010;155(2):55-6.
2009: Florian Wegner; Robert Kraft; Kathy Busse; Grit Schaarschmidt; Wolfgang Härtig; Sigrid C Schwarz; Johannes Schwarz
Glutamate receptor properties of human mesencephalic neural progenitor cells: NMDA enhances dopaminergic neurogenesis in vitro.
Journal of neurochemistry 2009;111(1):204-16.
2009: Eduard Kraft; Wolfgang Loichinger; Michael Diepers; Dorothée Lule; Johannes Schwarz; Albert C Ludolph; Alexander Storch
Levodopa-induced striatal activation in Parkinson's disease: a functional MRI study.
Parkinsonism & related disorders 2009;15(8):558-63.
2009: Philipp M Meyer; Karl Strecker; Kai Kendziorra; Georg Becker; Swen Hesse; Dominique Woelpl; Anke Hensel; Marianne Patt; Dietlind Sorger; Florian Wegner; Donald Lobsien; Henryk Barthel; Peter Brust; Hermann-Josef Gertz; Osama Sabri; Johannes Schwarz
Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.
Archives of general psychiatry 2009;66(8):866-77.
2009: Michael Sabolek; Bernd Baumann; Maria Heinrich; Anne K Meyer; Anna Herborg; Stefan Liebau; Martina Maisel; Andreas Hermann; Katharina Ventz; Johannes Schwarz; Thomas Wirth; Alexander Storch
Initiation of dopaminergic differentiation of Nurr1(-) mesencephalic precursor cells depends on activation of multiple mitogen-activated protein kinase pathways.
Stem cells (Dayton, Ohio) 2009;27(8):2009-21.
2009: Wolfgang Enard; Sabine Gehre; Kurt Hammerschmidt; Sabine M Hölter; Torsten Blass; Mehmet Somel; Martina K Brückner; Christiane Schreiweis; Christine Winter; Reinhard Sohr; Lore Becker; Victor Wiebe; Birgit Nickel; Thomas Giger; Uwe Müller; Matthias Groszer; Thure Adler; Antonio Aguilar; Ines Bolle; Julia Calzada-Wack; Claudia Dalke; Nicole Ehrhardt; Jack Favor; Helmut Fuchs; Valérie Gailus-Durner; Wolfgang Hans; Gabriele Hölzlwimmer; Anahita Javaheri; Svetoslav Kalaydjiev; Magdalena Kallnik; Eva Kling; Sandra Kunder; Ilona Mossbrugger; Beatrix Naton; Ildikó Racz; Birgit Rathkolb; Jan Rozman; Anja Schrewe; Dirk H Busch; Jochen Graw; Boris Ivandic; Martin Klingenspor; Thomas Klopstock; Markus Ollert; Leticia Quintanilla-Martinez; Holger Schulz; Eckhard Wolf; Wolfgang Wurst; Andreas Zimmer; Simon E Fisher; Rudolf Morgenstern; Thomas Arendt; Martin Hrabé de Angelis; Julia Fischer; Johannes Schwarz; Svante Pääbo
A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice.
Cell 2009;137(5):961-71.
2009: Patrizia Rubini; Javorina Milosevic; Johannes Engelhardt; Mahmoud Al-Khrasani; Heike Franke; Attilla Heinrich; Beata Sperlagh; Sigrid C Schwarz; Johannes Schwarz; Wolfgang Nörenberg; Peter Illes
Increase of intracellular Ca2+ by adenine and uracil nucleotides in human midbrain-derived neuronal progenitor cells.
Cell calcium 2009;45(5):485-98.
2009: Javorina Milosevic; Irena Adler; A Manaenko; Sigrid C Schwarz; Gail Walkinshaw; Michael Arend; Lee A Flippin; Alexander Storch; Johannes Schwarz
Non-hypoxic stabilization of hypoxia-inducible factor alpha (HIF-alpha): relevance in neural progenitor/stem cells.
Neurotoxicity research 2009;15(4):367-80.
2009: Donald G Grosset; Angelo Antonini; Margherita Canesi; Gianni Pezzoli; Andrew J Lees; Karen Shaw; Esther Cubo; Pablo Martinez-Martin; Olivier Rascol; Laurence Negre-Pages; Ana Senard; Johannes Schwarz; Karl Strecker; Heinz Reichmann; Alexander Storch; Matthias Löhle; Fabrizio Stocchi; Katherine A Grosset
Adherence to antiparkinson medication in a multicenter European study.
Movement disorders : official journal of the Movement Disorder Society 2009;24(6):826-32.
2009: Andreas Hermann; Christian Suess; Mareike Fauser; Sylvia Kanzler; Martin Witt; Klaus Fabel; Johannes Schwarz; Günter U Höglinger; Alexander Storch
Rostro-caudal gradual loss of cellular diversity within the periventricular regions of the ventricular system.
Stem cells (Dayton, Ohio) 2009;27(4):928-41.
2009: Grit Schaarschmidt; Sabine Schewtschik; Robert Kraft; Florian Wegner; Jens Eilers; Johannes Schwarz; Hartmut Schmidt
A new culturing strategy improves functional neuronal development of human neural progenitor cells.
Journal of neurochemistry 2009;109(1):238-47.
2009: Maja-Theresa Dieterlen; Florian Wegner; Sigrid C Schwarz; Javorina Milosevic; Barbara Schneider; Maria Busch; Ute Römuss; Annett Brandt; Alexander Storch; Johannes Schwarz
Non-viral gene transfer by nucleofection allows stable gene expression in human neural progenitor cells.
Journal of neuroscience methods 2009;178(1):15-23.
2009: Swen Hesse; Philipp M Meyer; Karl Strecker; Henryk Barthel; Florian Wegner; Christian Oehlwein; Ioannis Ugo Isaias; Johannes Schwarz; Osama Sabri
Monoamine transporter availability in Parkinson's disease patients with or without depression.
European journal of nuclear medicine and molecular imaging 2009;36(3):428-35.
2009: Grit Schaarschmidt; Florian Wegner; Sigrid C Schwarz; Hartmut Schmidt; Johannes Schwarz
Characterization of voltage-gated potassium channels in human neural progenitor cells.
PloS one 2009;4(7):e6168.
2009: Javorina Milosevic; Sigrid C Schwarz; Vera Ogunlade; Anne K Meyer; Alexander Storch; Johannes Schwarz
Emerging role of LRRK2 in human neural progenitor cell cycle progression, survival and differentiation.
Molecular neurodegeneration 2009;4():25.
2008: Karl Strecker; Jürgen Meixensberger; Johannes Schwarz; Dirk Winkler
Increase of frequency in deep brain stimulation relieves apraxia of eyelid opening in patients with Parkinson's disease: case report.
Neurosurgery 2008;63(6):E1204; discussion E1204.
2008: Karl Strecker; Johannes Schwarz
Parkinson's disease: emerging pharmacotherapy.
Expert opinion on emerging drugs 2008;13(4):573-91.
2008: Almut Focke; Sigrid Schwarz; Annette Förschler; Johanna Scheibe; Javorina Milosevic; Claus Zimmer; Johannes Schwarz
Labeling of human neural precursor cells using ferromagnetic nanoparticles.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2008;60(6):1321-8.
2008: Florian Wegner; Robert Kraft; Kathy Busse; Wolfgang Härtig; Grit Schaarschmidt; Sigrid C Schwarz; Johannes Schwarz; Wulf Hevers
Functional and molecular analysis of GABA receptors in human midbrain-derived neural progenitor cells.
Journal of neurochemistry 2008;107(4):1056-69.
2008: Michael Sabolek; Ines Mieskes; Thomas Lenk; Vera Lehmensiek; Andreas Hermann; Johannes Schwarz; Alexander Storch
Stage-dependent vulnerability of fetal mesencephalic neuroprogenitors towards dopaminergic neurotoxins.
Neurotoxicology 2008;29(4):714-21.
2008: Swen Hesse; Karl Strecker; Dirk Winkler; Julia Luthardt; Christoph Scherfler; Annegret Reupert; Christian Oehlwein; Henryk Barthel; Jens-Peter Schneider; Florian Wegner; Philipp Meyer; Jürgen Meixensberger; Osama Sabri; Johannes Schwarz
Effects of subthalamic nucleus stimulation on striatal dopaminergic transmission in patients with Parkinson's disease within one-year follow-up.
Journal of neurology 2008;255(7):1059-66.
2008: Johannes Schwarz; S Gratz; U Hahn; hans förstl; M Jarnig
[The status of imaging methods for the treatment of patients with Parkinson's syndrome].
Deutsche medizinische Wochenschrift (1946) 2008;133 Suppl 1():S8-10.
2008: S Gratz; U Hahn; J W Kaiser; M Jarnig; Johannes Schwarz; hans förstl
[Nuclear medicine imaging in neurodegenerative dementias].
Deutsche medizinische Wochenschrift (1946) 2008;133 Suppl 1():S5-7.
2008: U Hahn; Johannes Schwarz; S Gratz; J W Kaiser; M Jarnig; hans förstl
[Morphological magnetic resonance imaging: its value for the diagnosis of neurodegenerative diseases].
Deutsche medizinische Wochenschrift (1946) 2008;133 Suppl 1():S15-8.
2008: hans förstl; S Gratz; U Hahn; Johannes Schwarz; M Jarnig
[Dementia with Lewy bodies and reduced dopamine transporter binding indicates significant acetylcholine deficiency].
Deutsche medizinische Wochenschrift (1946) 2008;133 Suppl 1():S11-4.
2007: Florian Wegner; Karl Strecker; Johannes Schwarz; Armin Wagner; Wolfram Heinritz; Florian Sommerer; Dietmar R Thal; Jens-Peter Schneider; Kai Kendziorra; Osama Sabri
Vascular parkinsonism in a CADASIL case with an intact nigrostriatal dopaminergic system.
Journal of neurology 2007;254(12):1743-5.
2007: Karl Strecker; Swen Hesse; Florian Wegner; Osama Sabri; Johannes Schwarz; J-P Schneider
Eye of the tiger sign in multiple system atrophy.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2007;14(11):e1-2.
2007: Javorina Milosevic; Sigrid C Schwarz; Martina Maisel; Monika Poppe-Wagner; Maja-Theresa Dieterlen; Alexander Storch; Johannes Schwarz
Dopamine D2/D3 receptor stimulation fails to promote dopaminergic neurogenesis of murine and human midbrain-derived neural precursor cells in vitro.
Stem cells and development 2007;16(4):625-35.
2007: Christoph Scherfler; Johannes Schwarz; Angelo Antonini; Donald Grosset; Francesc Valldeoriola; Kenneth Marek; Wolfgang H Oertel; Eduardo Tolosa; Andrew J Lees; Werner Poewe
Role of DAT-SPECT in the diagnostic work up of parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 2007;22(9):1229-38.
2007: Martina Maisel; Alexander Herr; Javorina Milosevic; Andreas Hermann; Hans-Jörg Habisch; Sigrid Schwarz; Matthias Kirsch; Gregor Antoniadis; Rolf Brenner; Susanne Hallmeyer-Elgner; Holger Lerche; Johannes Schwarz; Alexander Storch
Transcription profiling of adult and fetal human neuroprogenitors identifies divergent paths to maintain the neuroprogenitor cell state.
Stem cells (Dayton, Ohio) 2007;25(5):1231-40.
2007: Karl Strecker; Jens-Peter Schneider; Osama Sabri; Florian Wegner; F Then Bergh; Johannes Schwarz; Swen Hesse
Responsiveness to a dopamine agent in Holmes tremor--case report.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2007;14(4):e9-e10.
2007: Javorina Milosevic; Martina Maisel; Florian Wegner; Julia Leuchtenberger; Roland H Wenger; Manfred Gerlach; Alexander Storch; Johannes Schwarz
Lack of hypoxia-inducible factor-1 alpha impairs midbrain neural precursor cells involving vascular endothelial growth factor signaling.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(2):412-21.
2007: Johannes Schwarz
Developmental perspectives on human midbrain-derived neural stem cells.
Parkinsonism & related disorders 2007;13 Suppl 3():S466-8.
2006: Alexander Storch; Yu-I Hwang; Gerhard Bringmann; Doris Feineis; S Ott; Ralph Brückner; Johannes Schwarz
Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cells.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(12):1895-901.
2006: Michael Sabolek; Anna Herborg; Johannes Schwarz; Alexander Storch
Dexamethasone blocks astroglial differentiation from neural precursor cells.
Neuroreport 2006;17(16):1719-23.
2006: Javorina Milosevic; Annett Brandt; Ute Roemuss; Antje Arnold; Florian Wegner; Sigrid C Schwarz; Alexander Storch; Herbert Zimmermann; Johannes Schwarz
Uracil nucleotides stimulate human neural precursor cell proliferation and dopaminergic differentiation: involvement of MEK/ERK signalling.
Journal of neurochemistry 2006;99(3):913-23.
2006: Philip Seeman; Johannes Schwarz; Jiang-Fan Chen; Henry Szechtman; Melissa Perreault; G Stanley McKnight; John C Roder; Rémi Quirion; Patricia Boksa; Lalit K Srivastava; Kazuhiko Yanai; David Weinshenker; Tomiki Sumiyoshi
Psychosis pathways converge via D2high dopamine receptors.
Synapse (New York, N.Y.) 2006;60(4):319-46.
2006: Swen Hesse; C Oehlwein; Henryk Barthel; Johannes Schwarz; D Polster; Armin Wagner; Osama Sabri
Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(9):1177-90.
2006: Karl Strecker; Jens-Peter Schneider; Henryk Barthel; Wieland Hermann; Florian Wegner; Armin Wagner; Johannes Schwarz; Osama Sabri; C Zimmer
Profound midbrain atrophy in patients with Wilson's disease and neurological symptoms?
Journal of neurology 2006;253(8):1024-9.
2006: Andreas Hermann; Martina Maisel; Stefan Liebau; Manfred Gerlach; Alexander Kleger; Johannes Schwarz; Kwang-Soo Kim; Gregor Antoniadis; Holger Lerche; Alexander Storch
Mesodermal cell types induce neurogenesis from adult human hippocampal progenitor cells.
Journal of neurochemistry 2006;98(2):629-40.
2006: Sigrid C Schwarz; Jan Wittlinger; Ralf Schober; Alexander Storch; Johannes Schwarz
Transplantation of human neural precursor cells in the 6-OHDA lesioned rats: effect of immunosuppression with cyclosporine A.
Parkinsonism & related disorders 2006;12(5):302-8.
2006: Andreas Hermann; Stefan Liebau; Regina Gastl; Stefan Fickert; Hans-Jörg Habisch; Jörg Fiedler; Johannes Schwarz; Rolf Brenner; Alexander Storch
Comparative analysis of neuroectodermal differentiation capacity of human bone marrow stromal cells using various conversion protocols.
Journal of neuroscience research 2006;83(8):1502-14.
2006: Javorina Milosevic; Franziska Juch; Alexander Storch; Johannes Schwarz
Low extracellular calcium is sufficient for survival and proliferation of murine mesencephalic neural precursor cells.
Cell and tissue research 2006;324(3):377-84.
2006: Johannes Schwarz; Sigrid C Schwarz; Oliver Dorigo; Alexandra Stützer; Florian Wegner; Cesar Labarca; Purnima Deshpande; Jose S Gil; Arnold J Berk; Henry A Lester
Enhanced expression of hypersensitive alpha4* nAChR in adult mice increases the loss of midbrain dopaminergic neurons.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(7):935-46.
2006: Johannes Schwarz; Engelbert Heimhilger; Alexander Storch
Increased periodontal pathology in Parkinson's disease.
Journal of neurology 2006;253(5):608-11.
2006: Vera Lehmensiek; Eva-Maria Tan; Stefan Liebau; Thomas Lenk; Heinz Zettlmeisl; Johannes Schwarz; Alexander Storch
Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
Neurochemistry international 2006;48(5):329-40.
2006: Andreas Hermann; Martina Maisel; Florian Wegner; Stefan Liebau; Dong-Wook Kim; Manfred Gerlach; Johannes Schwarz; Kwang-Soo Kim; Alexander Storch
Multipotent neural stem cells from the adult tegmentum with dopaminergic potential develop essential properties of functional neurons.
Stem cells (Dayton, Ohio) 2006;24(4):949-64.
2006: Wolfgang H Oertel; Erik C Wolters; Cristina Sampaio; Santiago Gimenez-Roldan; Bruno Bergamasco; Max Dujardin; Donald G Grosset; Guy Arnold; Klaus L Leenders; Hans-Peter Hundemer; Alberto Lledó; Andrew Wood; Paul Frewer; Johannes Schwarz
Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study.
Movement disorders : official journal of the Movement Disorder Society 2006;21(3):343-53.
2006: J-P Schneider; M Reinohs; Sascha Prothmann; Silvia Puccini; B Dalitz; Johannes Schwarz; C Zimmer; F Then Bergh
Subcortical Right Parietal AVM Rotational vertigo and caloric stimulation fMRI support a parietal representation of vestibular input.
Journal of neurology 2006;253(2):253-5.
2006: Florian Then Bergh; Alexander Niklas; Angelika Strauss; Nicolas von Ahsen; Dietger Niederwieser; Johannes Schwarz; Armin Wagner; Haifa-Kathrin Al-Ali
Rapid progression of Myelodysplastic syndrome to acute myeloid leukemia on sequential azathioprine, IFN-beta and copolymer-1 in a patient with multiple sclerosis.
Acta haematologica 2006;116(3):207-10.
2006: Johannes Schwarz; Sigrid C Schwarz; Alexander Storch
Developmental perspectives on human midbrain-derived neural stem cells.
Neuro-degenerative diseases 2006;3(1-2):45-9.
2005: Guy Arnold; Thomas Gasser; Alexander Storch; Axel Lipp; Andreas Kupsch; Hans-Peter Hundemer; Johannes Schwarz
High doses of pergolide improve clinical global impression in advanced Parkinson's disease:- a preliminary open label study.
Archives of gerontology and geriatrics 2005;41(3):239-53.
2005: Alexander Storch; Claudia Trenkwalder; Christian Oehlwein; Juliane Winkelmann; Udo Polzer; Hans-Peter Hundemer; Johannes Schwarz
High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
Parkinsonism & related disorders 2005;11(6):393-8.
2005: Dirk Winkler; Marc Tittgemeyer; Johannes Schwarz; Christoph Preul; Karl Strecker; Jürgen Meixensberger
The first evaluation of brain shift during functional neurosurgery by deformation field analysis.
Journal of neurology, neurosurgery, and psychiatry 2005;76(8):1161-3.
2005: Javorina Milosevic; Alexander Storch; Johannes Schwarz
Cryopreservation does not affect proliferation and multipotency of murine neural precursor cells.
Stem cells (Dayton, Ohio) 2005;23(5):681-8.
2005: Abraham Kovoor; Petra Seyffarth; Jana Ebert; Sami Barghshoon; Ching-Kang Chen; Sigrid Schwarz; Jeffrey D Axelrod; Benjamin N R Cheyette; Melvin I Simon; Henry A Lester; Johannes Schwarz
D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(8):2157-65.
2005: Javorina Milosevic; Sigrid C Schwarz; Knut Krohn; Monika Poppe; Alexander Storch; Johannes Schwarz
Low atmospheric oxygen avoids maturation, senescence and cell death of murine mesencephalic neural precursors.
Journal of neurochemistry 2005;92(4):718-29.
2005: Alexander Gerhard; Johannes Schwarz; Ralph Myers; Richard Wise; Richard B Banati
Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study.
NeuroImage 2005;24(2):591-5.
2005: Alexander Storch; Markus Kornhass; Johannes Schwarz
Testing for acanthocytosis A prospective reader-blinded study in movement disorder patients.
Journal of neurology 2005;252(1):84-90.
2004: Andrew R Tapper; Sheri McKinney; Raad Nashmi; Johannes Schwarz; Purnima Deshpande; Cesar Labarca; Paul Whiteaker; Michael J Marks; Allan C Collins; Henry A Lester
Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization.
Science (New York, N.Y.) 2004;306(5698):1029-32.
2004: Swen Hesse; Henryk Barthel; Johannes Schwarz; Osama Sabri; Ulrich Müller
Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders.
Neuroscience and biobehavioral reviews 2004;28(6):547-63.
2004: Alexander Storch; Michael Sabolek; Javorina Milosevic; Sigrid C Schwarz; Johannes Schwarz
Midbrain-derived neural stem cells: from basic science to therapeutic approaches.
Cell and tissue research 2004;318(1):15-22.
2004: Alexander Storch; Albert C Ludolph; Johannes Schwarz
Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(10-11):1267-86.
2004: Johannes Schwarz; Alexander Storch; Walter Koch; Oliver Pogarell; Perry E Radau; Klaus Tatsch
Loss of dopamine transporter binding in Parkinson's disease follows a single exponential rather than linear decline.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(10):1694-7.
2004: Thomas Müller; Harald Hefter; Roland Hueber; Wolfgang H Jost; Klaus L Leenders; Per Odin; Johannes Schwarz
Is levodopa toxic?
Journal of neurology 2004;251 Suppl 6():VI/44-6.
2004: Andreas Hermann; Regina Gastl; Stefan Liebau; M Oana Popa; Jörg Fiedler; Bernhard O Boehm; Martina Maisel; Holger Lerche; Johannes Schwarz; Rolf Brenner; Alexander Storch
Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells.
Journal of cell science 2004;117(Pt 19):4411-22.
2004: Sabine Orb; Johannes Wieacker; Cesar Labarca; Carlos Fonck; Henry A Lester; Johannes Schwarz
Knockin mice with Leu9'Ser alpha4-nicotinic receptors: substantia nigra dopaminergic neurons are hypersensitive to agonist and lost postnatally.
Physiological genomics 2004;18(3):299-307.
2004: Gabriele Pöpperl; Klaus Tatsch; E Ruzicka; A Storch; Thomas Gasser; Johannes Schwarz
Comparison of alpha-dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of changes in DAT binding with [123I]IPT SPECT.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(8):1041-52.
2004: P Günther; A Storch; Johannes Schwarz; Osama Sabri; P Steinbach; Armin Wagner; Swen Hesse
Basal ganglia involvement of a patient with SCA 17--a new form of autosomal dominant spinocerebellar ataxia.
Journal of neurology 2004;251(7):896-7.
2004: Alexander Storch; Yu-I Hwang; Debra A Gearhart; J Warren Beach; Edward J Neafsey; Michael A Collins; Johannes Schwarz
Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
Journal of neurochemistry 2004;89(3):685-94.
2004: Javorina Milosevic; Alexander Storch; Johannes Schwarz
Spontaneous apoptosis in murine free-floating neurospheres.
Experimental cell research 2004;294(1):9-17.
2004: Andreas Hermann; Manfred Gerlach; Johannes Schwarz; Alexander Storch
Neurorestoration in Parkinson's disease by cell replacement and endogenous regeneration.
Expert opinion on biological therapy 2004;4(2):131-43.
2003: Johannes Schwarz
Rationale for dopamine agonist use as monotherapy in Parkinson's disease.
Current opinion in neurology 2003;16 Suppl 1():S27-33.
2003: Alexander Storch; Henry A Lester; Bernhard O Boehm; Johannes Schwarz
Functional characterization of dopaminergic neurons derived from rodent mesencephalic progenitor cells.
Journal of chemical neuroanatomy 2003;26(2):133-42.
2003: Alexander Gerhard; Richard B Banati; G B Goerres; Annachiara Cagnin; R Myers; Roger Gunn; Federico E Turkheimer; C D Good; Christopher J Mathias; Niall Quinn; Johannes Schwarz; David J Brooks
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy.
Neurology 2003;61(5):686-9.
2003: Ilonka Eisensehr; Rainer Linke; Klaus Tatsch; Bita Kharraz; Josef F Gildehaus; Christian T Wetter; Claudia Trenkwalder; Johannes Schwarz; Soheyl Noachtar
Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls.
Sleep 2003;26(5):507-12.
2003: Zia Rahman; Johannes Schwarz; Stephen J Gold; Venetia Zachariou; Marc N Wein; Kwang Ho Choi; Abraham Kovoor; Ching-Kang Chen; Ralph J DiLeone; Sigrid C Schwarz; Dana E Selley; Laura J Sim-Selley; Michel Barrot; Robert R Luedtke; David W Self; Rachael L Neve; Henry A Lester; Melvin I Simon; Eric J Nestler
RGS9 modulates dopamine signaling in the basal ganglia.
Neuron 2003;38(6):941-52.
2003: Carlos Fonck; Raad Nashmi; Purnima Deshpande; M Imad Damaj; Michael J Marks; Anett Riedel; Johannes Schwarz; Allan C Collins; Cesar Labarca; Henry A Lester
Increased sensitivity to agonist-induced seizures, straub tail, and hippocampal theta rhythm in knock-in mice carrying hypersensitive alpha 4 nicotinic receptors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(7):2582-90.
2003: Heike Blessing; Markus Bareiss; Heinz Zettlmeisl; Johannes Schwarz; Alexander Storch
Catechol-O-methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicity.
Neurochemistry international 2003;42(2):139-51.
2002: Peter Riederer; Gabriele Gille; Thomas Müller; Horst Przuntek; Heinz Reichmann; Olaf Riess; A Schwartz; Johannes Schwarz; T Vogt
Practical importance of neuroprotection in Parkinson's disease.
Journal of neurology 2002;249 Suppl 3():III/53-6.
2002: Manfred Gerlach; Heiko Braak; A Hartmann; W H Jost; P Odin; J Priller; Johannes Schwarz
Current state of stem cell research for the treatment of Parkinson's disease.
Journal of neurology 2002;249 Suppl 3():III/33-5.
2002: Alexander Storch; Johannes Schwarz
Neural stem cells and Parkinson's disease.
Journal of neurology 2002;249 Suppl 3():III/30-2.
2002: Vera Lehmensiek; Eva-Maria Tan; Johannes Schwarz; Alexander Storch
Expression of mutant alpha-synucleins enhances dopamine transporter-mediated MPP+ toxicity in vitro.
Neuroreport 2002;13(10):1279-83.
2002: Guy Arnold; Klaus Tatsch; Eduardo Kraft; Wolfgang H Oertel; Johannes Schwarz
Steele-Richardson-Olszewski-syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: (123)IBZM SPECT and MRI study.
Movement disorders : official journal of the Movement Disorder Society 2002;17(3):557-62.
2002: Alexander Storch; Johannes Schwarz
Neural stem cells and neurodegeneration.
Current opinion in investigational drugs (London, England : 2000) 2002;3(5):774-81.
2002: Guy Arnold; Johannes Schwarz; Klaus Tatsch; Eduardo Kraft; T Wächter; O Bandmann; Wolfgang H Oertel
Steele-Richardson-Olszewski-syndrome: the relation of dopamine D2 receptor binding and subcortical lesions in MRI.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(4):503-12.
2002: Alexander Storch; Stefanie Ott; Yu-I Hwang; Rainer Ortmann; Andreas Hein; Stefan Frenzel; Kazuo Matsubara; Shigeru Ohta; Hans Uwe Wolf; Johannes Schwarz
Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
Biochemical pharmacology 2002;63(5):909-20.
2001: Alexander Storch; G Paul; M Csete; B O Boehm; Paul Carvey; Andreas Kupsch; Johannes Schwarz
Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells.
Experimental neurology 2001;170(2):317-25.
2001: M Chouker; Klaus Tatsch; Rainer Linke; Oliver Pogarell; Klaus Hahn; Johannes Schwarz
Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 years.
Nuclear medicine communications 2001;22(6):721-5.
2001: Cesar Labarca; Johannes Schwarz; Purnima Deshpande; S Schwarz; Mark W Nowak; Carlos Fonck; Raad Nashmi; Paulo Kofuji; H Dang; W Shi; melihat fidan; Baljit S Khakh; Z Chen; B J Bowers; Jim Boulter; Jeanne M Wehner; Henry A Lester
Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(5):2786-91.
2001: Andreas Kupsch; Jürgen Sautter; Mario E Götz; Wolfram Breithaupt; Johannes Schwarz; Moussa B H Youdim; Peter Riederer; Manfred Gerlach; Wolfgang H Oertel
Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(8-9):985-1009.
2000: Alexander Storch; K Burkhardt; Albert C Ludolph; Johannes Schwarz
Protective effects of riluzole on dopamine neurons: involvement of oxidative stress and cellular energy metabolism.
Journal of neurochemistry 2000;75(6):2259-69.
2000: Ilonka Eisensehr; Rainer Linke; Soheyl Noachtar; Johannes Schwarz; Franz-Josef Gildehaus; Klaus Tatsch
Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls.
Brain : a journal of neurology 2000;123 ( Pt 6)():1155-60.
2000: T S Benamer; Jim Patterson; Donald G Grosset; Jan Booij; Kora de Bruin; EA van Royen; Johannes D Speelman; Martin Horstink; H J Sips; R A Dierckx; Jan Versijpt; Danny Decoo; C Van Der Linden; Donald M Hadley; M Doder; Andrew J Lees; Durval C Costa; Svetislav Gacinovic; Wolfgang H Oertel; Oliver Pogarell; Helmut Hoeffken; K Joseph; K Tatsch; Johannes Schwarz; V Ries
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):503-10.
2000: Alexander Storch; Heike Blessing; M Bareiss; S Jankowski; ZD Ling; Paul Carvey; Johannes Schwarz
Catechol-O-methyltransferase inhibition attenuates levodopa toxicity in mesencephalic dopamine neurons.
Molecular pharmacology 2000;57(3):589-94.
2000: Alexander Storch; A Kaftan; K Burkhardt; Johannes Schwarz
1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism.
Brain research 2000;855(1):67-75.
2000: Johannes Schwarz; R Linke; M Kerner; P D Mozley; Claudia Trenkwalder; Thomas Gasser; K Tatsch
Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis.
Archives of neurology 2000;57(2):205-8.
2000: Alexander Storch; A Kaftan; K Burkhardt; Johannes Schwarz
6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(3):281-93.
1999: Anne-Dorte Sperfeld; M B Collatz; H Baier; M Palmbach; Alexander Storch; Johannes Schwarz; K Tatsch; S Reske; M Joosse; Peter Heutink; Albert C Ludolph
FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation.
Annals of neurology 1999;46(5):708-15.
1999: Alexander Storch; Albert C Ludolph; Johannes Schwarz
HEK-293 cells expressing the human dopamine transporter are susceptible to low concentrations of 1-methyl-4-phenylpyridine (MPP+) via impairment of energy metabolism.
Neurochemistry international 1999;35(5):393-403.
1999: Johannes Schwarz; Eduardo Kraft; T Vogl; Guy Arnold; Klaus Tatsch; Wolfgang H Oertel
Relative quantification of signal on T2-weighted images in the basal ganglia: limited value in differential diagnosis of patients with parkinsonism.
Neuroradiology 1999;41(2):124-8.
1999: Eduardo Kraft; Johannes Schwarz; Claudia Trenkwalder; T Vogl; T Pfluger; Wolfgang H Oertel
The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy?
Archives of neurology 1999;56(2):225-8.
1998: S C Schwarz; Thomas Seufferlein; Susanne Liptay; Roland M Schmid; K Kasischke; O J Foster; S Daniel; Johannes Schwarz
Microglial activation in multiple system atrophy: a potential role for NF-kappaB/rel proteins.
Neuroreport 1998;9(13):3029-32.
1998: Gian Domenico Borasio; Rainer Linke; Johannes Schwarz; V Schlamp; A Abel; PD Mozley; Klaus Tatsch
Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography.
Journal of neurology, neurosurgery, and psychiatry 1998;65(2):263-5.
1998: Johannes Schwarz; J Scherer; Claudia Trenkwalder; PD Mozley; Klaus Tatsch
Reduced striatal dopaminergic innervation shown by IPT and SPECT in patients under neuroleptic treatment: need for levodopa therapy?
Psychiatry research 1998;83(1):23-8.
1998: S C Schwarz; Johannes Schwarz; Jürgen Sautter; Wolfgang H Oertel
Effects of macrophage migration inhibitory factor and macrophage migration stimulatory factor on function and survival of foetal dopaminergic grafts in the 6-hydroxydopamine rat model of Parkinson's disease.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1998;120(1):95-103.
1998: Mario E Götz; Wolfram Breithaupt; Jürgen Sautter; Andreas Kupsch; Johannes Schwarz; Wolfgang H Oertel; Moussa B H Youdim; Peter Riederer; Manfred Gerlach
Chronic TVP-1012 (rasagiline) dose--activity response of monoamine oxidases A and B in the brain of the common marmoset.
Journal of neural transmission. Supplementum 1998;52():271-8.
1998: Johannes Schwarz; Klaus Tatsch; Thomas Gasser; Guy Arnold; Oliver Pogarell; G Künig; Wolfgang H Oertel
123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 1998;13(1):16-9.
1997: Guy Arnold; Johannes Schwarz; C Macher; Wolfgang H Oertel
Domperidone is superior to ondansetron in acute apomorphine challenge in previously untreated parkinsonian patients - A double blind study.
Parkinsonism & related disorders 1997;3(4):191-3.
1997: Andreas Kupsch; Oliver Pogarell; Johannes Schwarz; A Straube; Wolfgang H Oertel; Klaus Tatsch; Rainer Linke
Parkinson's disease and tumour in the supplementary motor area: a re-evaluation.
Journal of neurology, neurosurgery, and psychiatry 1997;63(6):811-2.
1997: Johannes Schwarz; Klaus Tatsch; Thomas Gasser; Guy Arnold; Wolfgang H Oertel
[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):898-902.
1997: M Plaschke; Johannes Schwarz; H Dahlheim; Herbert Backmund; Claudia Trenkwalder
Cardiovascular and renin responses to head-up tilt tests in parkinsonism.
Acta neurologica Scandinavica 1997;96(4):206-10.
1997: Johannes Schwarz; M Kornhuber; C Bischoff; A Straube
Electromyography of the external anal sphincter in patients with Parkinson's disease and multiple system atrophy: frequency of abnormal spontaneous activity and polyphasic motor unit potentials.
Muscle & nerve 1997;20(9):1167-72.
1997: K Scheidtmann; Johannes Schwarz; E Holinski; T Gasser; Claudia Trenkwalder
Paroxysmal choreoathetosis--a disorder related to Huntington's disease?
Journal of neurology 1997;244(6):395-8.
1997: Johannes Schwarz; J Planck; J Briegel; A Straube
Single-fiber electromyography, nerve conduction studies, and conventional electromyography in patients with critical-illness polyneuropathy: evidence for a lesion of terminal motor axons.
Muscle & nerve 1997;20(6):696-701.
1997: Q Lin; Johannes Schwarz; C Bucana; Eric N Olson
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C.
Science (New York, N.Y.) 1997;276(5317):1404-7.
1997: Armin Welz; Oliver Pogarell; Klaus Tatsch; Johannes Schwarz; K Cryssagis; Bruno Reichart
Surgery of the thoracic aorta using deep hypothermic total circulatory arrest. Are there neurological consequences other than frank cerebral defects?
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 1997;11(4):650-6.
1997: Klaus Tatsch; Johannes Schwarz; PD Mozley; Rainer Linke; Oliver Pogarell; Wolfgang H Oertel; R S Fieber; Klaus Hahn; Hank F Kung
Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography.
European journal of nuclear medicine 1997;24(4):415-21.
1997: Johannes Schwarz; K Scheidtmann; Claudia Trenkwalder
Improvement of motor fluctuations in patients with Parkinson's disease following treatment with high doses of pergolide and cessation of levodopa.
European neurology 1997;37(4):236-8.
1997: J Scherer; Klaus Tatsch; Margot Albus; Johannes Schwarz; T Mager; Wolfgang H Oertel
D2-dopamine-receptor occupancy during treatment with haloperidol decanoate.
European archives of psychiatry and clinical neuroscience 1997;247(2):104-6.
1997: Angelo Antonini; Johannes Schwarz; Wolfgang H Oertel; O Pogarell; Klaus L Leenders
Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Movement disorders : official journal of the Movement Disorder Society 1997;12(1):33-8.
1996: Andreas Kupsch; Jürgen Sautter; Johannes Schwarz; Peter Riederer; Manfred Gerlach; Wolfgang H Oertel
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
Brain research 1996;741(1-2):185-96.
1996: Johannes Schwarz; Wolfgang H Oertel; Klaus Tatsch
Iodine-123-iodobenzamide binding in parkinsonism: reduction by dopamine agonists but not L-Dopa.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(7):1112-5.
1996: T E Eichhorn; Thomas Gasser; N Mai; Christian Marquardt; Guy Arnold; Johannes Schwarz; Wolfgang H Oertel
Computational analysis of open loop handwriting movements in Parkinson's disease: a rapid method to detect dopamimetic effects.
Movement disorders : official journal of the Movement Disorder Society 1996;11(3):289-97.
1996: Manfred Gerlach; Mario E Götz; A Dirr; Andreas Kupsch; B Janetzky; Wolfgang H Oertel; Jürgen Sautter; Johannes Schwarz; Heinz Reichmann; Peter Riederer
Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin.
Neurochemistry international 1996;28(1):41-9.
1996: Johannes Schwarz; S Weis; E Kraft; Klaus Tatsch; O Bandmann; Parviz Mehraein; T Vogl; Wolfgang H Oertel
Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy.
Journal of neurology, neurosurgery, and psychiatry 1996;60(1):98-101.
1995: Claudia Trenkwalder; Karin Stiasny; Thomas Pollmächer; Thomas C Wetter; Johannes Schwarz; Ralf Kohnen; J Kazenwadel; H P Krüger; S Ramm; M Künzel
L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.
Sleep 1995;18(8):681-8.
1995: Claudia Trenkwalder; Johannes Schwarz; J Gebhard; D Ruland; Peter Trenkwalder; Hans-Werner Hense; Wolfgang H Oertel
Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of Parkinson's disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years.
Archives of neurology 1995;52(10):1017-22.
1995: T F Schwarz; Hans-Walter Pfister; Johannes Schwarz; C Pauli; Gabriele Jäger
[Meningitis after travel in the Mediterranean region, caused by the sandfly fever virus].
Der Nervenarzt 1995;66(10):789-91.
1995: Wolfgang H Oertel; Claudia Trenkwalder; Thomas Gasser; Johannes Schwarz; SF Bucher; T Eichhorn; Oliver Pogarell; G Künig; Guy Arnold; O Bandmann
Epidemiological, genetic, pharmacological, kinesiological, nuclear medical (IBZM-SPECT), standard and functional MRI studies on Parkinson's disease and related disorders and economic evaluation of Parkinson's disease therapy--clinical projects in the BMFT-research program Munich: "Parkinson's disease and other basal ganglia disorders".
Journal of neural transmission. Supplementum 1995;46():325-37.
1994: J Scherer; Klaus Tatsch; Johannes Schwarz; Wolfgang H Oertel; M C Kirsch; Margot Albus
Striatal D2-dopamine receptor occupancy during treatment with typical and atypical neuroleptics.
Biological psychiatry 1994;36(9):627-9.
1994: Johannes Schwarz; Angelo Antonini; Klaus Tatsch; Carl-Martin Kirsch; Wolfgang H Oertel; Klaus L Leenders
Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonism.
Nuclear medicine communications 1994;15(10):806-13.
1994: J Scherer; Klaus Tatsch; Johannes Schwarz; Wolfgang H Oertel; M Konjarczyk; Margot Albus
D2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effects.
Acta psychiatrica Scandinavica 1994;90(4):266-8.
1994: Angelo Antonini; Johannes Schwarz; Wolfgang H Oertel; H F Beer; U D Madeja; Klaus L Leenders
[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors.
Neurology 1994;44(7):1325-9.
1994: Johannes Schwarz; Angelo Antonini; E Kraft; Klaus Tatsch; T Vogl; Carl-Martin Kirsch; Klaus L Leenders; Wolfgang H Oertel
Treatment with D-penicillamine improves dopamine D2-receptor binding and T2-signal intensity in de novo Wilson's disease.
Neurology 1994;44(6):1079-82.
1994: G Arnold; C Trenkwalder; Johannes Schwarz; Wolfgang H Oertel
Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.
Movement disorders : official journal of the Movement Disorder Society 1994;9(2):238-40.
1994: Guy Arnold; Klaus Tatsch; Wolfgang H Oertel; T Vogl; Johannes Schwarz; E Kraft; Carl-Martin Kirsch
Clinical progressive supranuclear palsy: differential diagnosis by IBZM-SPECT and MRI.
Journal of neural transmission. Supplementum 1994;42():111-8.
1993: Johannes Schwarz; Klaus Tatsch; Guy Arnold; M Ott; Claudia Trenkwalder; Carl-Martin Kirsch; Wolfgang H Oertel
123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism.
Neurology 1993;43(12 Suppl 6):S17-20.
1993: T Baumert; G Kleber; Johannes Schwarz; Axel Stäbler; Rolf Lamerz; Klaus Mann
Reversible hyperkinesia in a patient with autoimmune polyglandular syndrome type I.
The Clinical investigator 1993;71(11):924-7.
1993: Wolfgang H Oertel; Johannes Schwarz; Klaus Tatsch; Guy Arnold; Thomas Gasser; Carl-Martin Kirsch
IBZM-SPECT as predictor for dopamimetic responsiveness of patients with de novo parkinsonian syndrome.
Advances in neurology 1993;60():519-24.
1993: Guy Arnold; Brigitta Bondy; O Bandmann; Thomas Gasser; Johannes Schwarz; Claudia Trenkwalder; M Wagner; Werner Poewe; Wolfgang H Oertel
3H-spiperone binding to lymphocytes fails in the differential diagnosis of de novo Parkinson syndromes.
Journal of neural transmission. Parkinson's disease and dementia section 1993;5(2):107-16.
1992: Wolfgang H Oertel; Klaus Tatsch; Johannes Schwarz; E Kraft; Claudia Trenkwalder; J Scherer; M Weinzierl; T Vogl; Carl-Martin Kirsch
Decrease of D2 receptors indicated by 123I-iodobenzamide single-photon emission computed tomography relates to neurological deficit in treated Wilson's disease.
Annals of neurology 1992;32(6):743-8.
1992: T Gasser; Johannes Schwarz; G Arnold; C Trenkwalder; Wolfgang H Oertel
Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease.
Archives of neurology 1992;49(11):1131-4.
1992: Johannes Schwarz; Klaus Tatsch; Guy Arnold; Thomas Gasser; Claudia Trenkwalder; Carl-Martin Kirsch; Wolfgang H Oertel
123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism.
Neurology 1992;42(3 Pt 1):556-61.
1992: Johannes Schwarz; Claudia Trenkwalder; Thomas Gasser; Guy Arnold; Wolfgang H Oertel
Folinic acid therapy fails to improve early Parkinson's disease: a two week placebo controlled clinical trial.
Journal of neural transmission. Parkinson's disease and dementia section 1992;4(1):35-41.
1992: Johannes Schwarz; Klaus Tatsch; T Vogl; Carl-Martin Kirsch; Claudia Trenkwalder; Guy Arnold; Thomas Gasser; Wolfgang H Oertel
Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia.
Movement disorders : official journal of the Movement Disorder Society 1992;7(1):58-61.
1991: Klaus Tatsch; Johannes Schwarz; Wolfgang H Oertel; Carl-Martin Kirsch
SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease.
Nuclear medicine communications 1991;12(8):699-707.
1990: M Gupta; Johannes Schwarz; X L Chen; Fred Roisen
Gangliosides prevent MPTP toxicity in mice--an immunocytochemical study.
Brain research 1990;527(2):330-4.
1988: Joachim Mössner; Johannes Schwarz; Wolfgang Fischbach
Influence of "calcium2+-channel blockers" on exocrine pancreatic secretion by isolated rat acini.
Research in experimental medicine. Zeitschrift für die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie 1988;188(4):255-65.